Q1 FY27 results: consolidated PAT up 35%, revenue up 24%; internal restructuring

Revenue Growth 20pctPat Growth 25pctRelated Party TransactionsResults View source PDF Explain this filing

NEPHROPLUS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-5.3%Reaction day

₹716.95

prior close

₹725.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.4%-5.7% vs market

Healthcare Service Provider peers, median of 26sector+0.0%-5.3% vs sector

On the reaction day the stock moved 5.7 pts less than Nifty Microcap 250 and 5.3 pts less than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-2.8

10m

-2.9

15m

-3.6

30m

-2.7

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-5.3+0.4-5.7+0.0-5.3

Next day

-5.0+0.5-5.6+0.4-5.4

-2.4+0.6-3.0-2.2-0.2

-3.1+0.7-3.8-0.7-2.4

-2.6+1.1-3.8-1.9-0.7

-4.3+0.5-4.8-2.3-2.0

-3.6+1.3-4.9-1.4-2.3

15d

-2.9+0.5-3.4-0.0-2.9

+1.7-0.8+2.5-2.3+4.0

-13.9-0.9-13.0-2.6-11.3

—————

UpDownMarket · Nifty Microcap 250Sector · Healthcare Service Provider peers, median of 26Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Nephrocare Health Services reported Q1 FY27 results. Standalone revenue rose 14.5 percent to Rs 1,703.78 million; standalone PAT jumped to Rs 125.63 million from Rs 50.14 million (EPS Rs 1.25). Consolidated revenue grew 23.7 percent to Rs 2,817.54 million with PAT up 34.9 percent at Rs 319.74 million (EPS Rs 3.19). India contributed Rs 1,553.79 million revenue. Board also approved transfer of 51 percent Saudi JV stake between wholly-owned subsidiaries for SAR 2.24 million as internal restructuring with no change in ultimate ownership.

Likely market impact

Strong quarterly profit growth across India and overseas. Internal restructuring is ownership-neutral for shareholders.